日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 2 trial of paclitaxel polyglumex with capecitabine for metastatic breast cancer

紫杉醇聚谷氨酰胺联合卡培他滨治疗转移性乳腺癌的II期临床试验

Northfelt, Donald W; Allred, Jacob B; Liu, Heshan; Hobday, Timothy J; Rodacker, Mark W; Lyss, Alan P; Fitch, Tom R; Perez, Edith A

Inhibition of phosphorylation of na+,k+-ATPase by mutations causing familial hemiplegic migraine

家族性偏瘫性偏头痛的致病突变抑制Na+,K+-ATP酶的磷酸化

Schack, Vivien Rodacker; Holm, Rikke; Vilsen, Bente

The structure of the Na+,K+-ATPase and mapping of isoform differences and disease-related mutations

Na+,K+-ATPase的结构、同工型差异及疾病相关突变的定位

Morth, J Preben; Poulsen, Hanne; Toustrup-Jensen, Mads S; Schack, Vivien Rodacker; Egebjerg, Jan; Andersen, Jens Peter; Vilsen, Bente; Nissen, Poul

The C terminus of Na+,K+-ATPase controls Na+ affinity on both sides of the membrane through Arg935

Na+,K+-ATPase 的 C 末端通过 Arg935 控制膜两侧的 Na+ 亲和力。

Toustrup-Jensen, Mads S; Holm, Rikke; Einholm, Anja Pernille; Schack, Vivien Rodacker; Morth, J Preben; Nissen, Poul; Andersen, Jens Peter; Vilsen, Bente